Skip to main content

Table 1 Demographic, clinical and virological features of the study patients

From: Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations

Patient

Age

(yrs)

Gender*

Time of

Infection

(yrs)

Total time on

HAART

(yrs)

NADIR CD4

(cells/microliter

CD4

T0**

(cells/microliter)

HIV-RNA

T0**

(Log10cp/ml)

CD4

T1***

(cells/microliter)

HIV-RNA

T1***

(Log10cp/ml)

Pt.1

48

F

18

6

312

569

<1.7

598

3,30

Pt.2

37

M

11

10

438

1093

<1.7

1162

1,92

Pt.3

52

M

8

7

336

699

<1.7

520

> 5,70

Pt.4

41

M

10

9

246

697

<1.7

428

5,25

Pt.5

50

F

17

9

223

792

<1.7

511

5,60

  1. * M, male; F, female.
  2. ** T0: at the time of HAART interruption
  3. *** T1: one month after HAART interruption